{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:54:48Z","timestamp":1787874888670,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"All India Council for Technical Education (AICTE), New Delhi, India"},{"name":"Department of Pharmacology, Faculty of Pharmacy, Hamdard University, India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.pbb.2013.12.015","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T07:00:16Z","timestamp":1387350016000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Interactions of atenolol with alprazolam\/escitalopram on anxiety, depression and oxidative stress"],"prefix":"10.1016","volume":"117","author":[{"given":"Naiyer","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajahatullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed S.","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ruhal","family":"Ain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Abdel Aziz","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razia","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0006-8993(77)90083-X","article-title":"Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus","volume":"136","author":"Aghajanian","year":"1977","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.pbb.2013.12.015_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF03345110","article-title":"Benzodiazepines and anterior pituitary function","volume":"25","author":"Arvat","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2012.07.024","article-title":"Angiotensin-(1\u20137) central administration induces anxiolytic-like effects on elevated-plus maze and decreased oxidative stress in the amygdale","volume":"145","author":"Bild","year":"2013","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2013.12.015_bb0280","series-title":"Handbook of psychopharmacology","first-page":"285","article-title":"Benzodiazepine receptor","author":"Braestrup","year":"1983"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","article-title":"Don't worry \u2018B\u2019 happy!: a role for GABAB receptors in anxiety and depression","volume":"26","author":"Cryan","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.pbb.2013.12.015_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"4\u20135","key":"10.1016\/j.pbb.2013.12.015_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2165\/00003495-198427020-00002","article-title":"Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression","volume":"27","author":"Dawson","year":"1984","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"De Chiara","year":"2012","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0091-3057(86)90012-2","article-title":"The anti-anxiety effect of beta-blockers on punished responding","volume":"25","author":"Durel","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.12.015_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.12.015_bb0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.pnpbp.2005.11.011","article-title":"Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in rat model of depression","volume":"30","author":"El Khoury","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl group","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0091-3057(95)02175-2","article-title":"Recent developments in anxiety, stress, and depression","volume":"54","author":"File","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pbb.2013.12.015_bb0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hup.1014","article-title":"Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients","volume":"24","author":"Ga\u0142ecki","year":"2009","journal-title":"Hum Psychopharmacol"},{"issue":"7","key":"10.1016\/j.pbb.2013.12.015_bb0090","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0895-4356(96)00017-0","article-title":"The incidence of depression in new users of beta blockers and selected hypertensives","volume":"49","author":"Gerstman","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.pbb.2013.12.015_bb0095","first-page":"453","article-title":"Depressive symptoms in propranolol users","volume":"47","author":"Griffin","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0100","first-page":"21","article-title":"Combined study of atenolol and escitalopram on anxiety and depression","volume":"2","author":"Gulshan","year":"2013","journal-title":"Int J Tech Res"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/j.1875-9114.1983.tb04546.x","article-title":"The use of beta adrenergic blocking agents in anxiety disorders and schizophrenia","volume":"3","author":"Hayes","year":"1983","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2006.03.009","article-title":"Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety","volume":"51","author":"Hogg","year":"2006","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nurx.2005.12.007","article-title":"Advances in the treatment of depression","volume":"3","author":"Holtzheimer","year":"2006","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2008.12.024","article-title":"Effects of fluoxetine on the rat brain in the forced swimming test: a [F-18] FDG micro-PET imaging study","volume":"451","author":"Jang","year":"2009","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.pbb.2013.12.015_bb0125","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ophtha.2006.02.056","article-title":"Topical blockers are not associated with an increased risk of treatment for depression","volume":"113","author":"Kaiserman","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.pbb.2013.12.015_bb0130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"21","key":"10.1016\/j.pbb.2013.12.015_bb0135","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1523\/JNEUROSCI.17-21-08451.1997","article-title":"Reduced levels of norepinephrine transporters in the locus coeruleus in major depression","volume":"17","author":"Klimek","year":"1997","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbr.2009.03.004","article-title":"The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex","volume":"201","author":"Koenigs","year":"2009","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.pnpbp.2010.08.026","article-title":"In animal models, psychosocial stress-induced (neuro) inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression","volume":"35","author":"Kubera","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2013.12.015_bb0150","first-page":"785","article-title":"Effect of citalopram in the modified forced swim test in rats","volume":"59","author":"Ku\u015bmider","year":"2007","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0285","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"Le'pine","year":"2011","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2011.11.013","article-title":"Effects of GABA ligands injected into the nucleus accumbens shell on fear\/anxiety-like and feeding behaviours in food-deprived rats","volume":"101","author":"Lopes","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pbb.2013.12.015_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0893-133X(00)00208-6","article-title":"Glutathione depletion, lipid peroxidation and mitochondria! dysfunction are induced by chronic stress in rat brain","volume":"24","author":"Madrigal","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0175","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"41","key":"10.1016\/j.pbb.2013.12.015_bb0180","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1192\/bjp.178.41.s107","article-title":"Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers","volume":"178","author":"Manji","year":"2001","journal-title":"Br J Psychiatry Suppl"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.108.137208","article-title":"Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice","volume":"326","author":"Masood","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2013.12.015_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.psychres.2006.04.013","article-title":"Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder a postmortem study","volume":"151","author":"Michel","year":"2007","journal-title":"Psychiatry Res"},{"issue":"7","key":"10.1016\/j.pbb.2013.12.015_bb0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.mppsy.2007.04.005","article-title":"Specific treatments and disorders: antidepressants","volume":"6","author":"Nash","year":"2007","journal-title":"Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2013.12.015_bb0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders, evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2013.12.015_bb0205","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1016\/S0924-977X(00)00110-3","article-title":"Treatment of depression and concomitant anxiety","volume":"10","author":"Nutt","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2013.12.015_bb0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(94)00392-V","article-title":"\u03b2-adrenergic receptor subtypes in stress-induced behavioral depression","volume":"51","author":"Pandey","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/070674379003500312","article-title":"Propranolol and depression: evidence from the antihypertensive trials","volume":"35","author":"Patten","year":"1990","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated-plus maze as a measure of anxiety in rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J Neurosci Methods"},{"issue":"9","key":"10.1016\/j.pbb.2013.12.015_bb0230","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0006-3223(95)00049-7","article-title":"Benzodiazepines as antidepressants: does GABA play a role in depression?","volume":"38","author":"Petty","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2013.12.015_bb0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2006.09.027","article-title":"Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic pituitary adrenocortical (HPA) system regulation","volume":"62","author":"Reppermund","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2013.12.015_bb0290","first-page":"524","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"7","author":"Schildkraut","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.pbb.2013.12.015_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res Rev"},{"issue":"6","key":"10.1016\/j.pbb.2013.12.015_bb9000","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0278-5846(03)00162-3","article-title":"Psychoneuroendocrinological links between chronic stress and depression","volume":"27","author":"Tafet","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2013.12.015_bb0250","first-page":"297","article-title":"Alprazolam\u2014a new triazolobenzodiazepine","volume":"66","author":"Talmud","year":"1984","journal-title":"S Afr Med J"},{"issue":"3","key":"10.1016\/j.pbb.2013.12.015_bb0255","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0091-3057(91)90134-N","article-title":"Anxiolytic-like action of beta blockers: effect of stimulus salience","volume":"39","author":"Terry","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2005.12.010","article-title":"Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants","volume":"91","author":"Tsuboi","year":"2006","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.pbb.2013.12.015_bb0265","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ddmec.2004.11.021","article-title":"Mechanisms of depression: role of the HPA axis","volume":"1","author":"Van Den Eede","year":"2004","journal-title":"Drug Discov Today Dis Mech"},{"issue":"1","key":"10.1016\/j.pbb.2013.12.015_bb0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hfc.2010.08.006","article-title":"A review on the putative association between beta-blockers and depression","volume":"7","author":"Verbeek","year":"2011","journal-title":"Heart Fail Clin"},{"issue":"6","key":"10.1016\/j.pbb.2013.12.015_bb0275","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0278-5846(90)90073-P","article-title":"Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swimming test","volume":"14","author":"West","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2013.12.015_bb0295","first-page":"148","article-title":"Alprazolam as an antidepressant","volume":"49","author":"Warner","year":"1988","journal-title":"J Clin Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713003493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713003493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T23:16:35Z","timestamp":1647731795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713003493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":57,"alternative-id":["S0091305713003493"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.12.015","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions of atenolol with alprazolam\/escitalopram on anxiety, depression and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}